Table 5.
Agreement between clinical site PI and Medical Safety Monitors
| Serious | Unexpected | Related to Study Drug | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PI | MSM1 | MSM2 | N | % | PI | MSM1 MSM2 | N | % | PI | MSM1 MSM2 | N | % | ||
| Yes | Yes | Yes | 384 | 92.5 | Yes | Yes | Yes | 190 | 45.8 | Yes | Yes | Yes | 23 | 5.5 |
| Yes | Yes | No | 10 | 2.4 | Yes | Yes | No | 105 | 25.3 | Yes | Yes | No | 1 | 0.2 |
| Yes | Yes | --- | 4 | 1.0 | Yes | Yes | --- | 3 | 0.7 | Yes | Yes | --- | 2 | 0.5 |
| Yes | No | Yes | 11 | 2.7 | Yes | No | Yes | 5 | 1.2 | Yes | No | Yes | 5 | 1.2 |
| Yes | --- | Yes | 1 | 0.2 | Yes | No | No | 12 | 2.9 | Yes | No | No | 2 | 0.5 |
| Yes | --- | --- | 2 | 0.5 | Yes | --- | Yes | 1 | 0.2 | No | No | No | 344 | 82.9 |
| No | Yes | Yes | 1 | 0.2 | No | No | No | 32 | 7.7 | No | Yes | Yes | 1 | 0.2 |
| No | Yes | No | 1 | 0.2 | No | No | Yes | 11 | 2.7 | No | Yes | No | 2 | 0.5 |
| No | Yes | No | 27 | 6.5 | No | No | Yes | 29 | 7.0 | |||||
| No | Yes | Yes | 25 | 6.0 | No | No | --- | 2 | 0.5 | |||||
| No | Yes | --- | 1 | 0.2 | No | --- | No | 2 | 0.5 | |||||
| No | --- | No | 1 | 0.2 | No | --- | --- | 2 | 0.5 | |||||
| No | 2 | 0.5 | ||||||||||||